Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies.
It also offers secondary sample technology consumables, such as kits and components for purification of nucleic acids, and instruments for nucleic acid purification, quality control, and accessories. Additionally, Qiagen provides immune response consumables, such as interferon-gamma release assays for TB testing, and assays for post-transplant testing and viral load monitoring.
The company also focuses on oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants. Their sample to insight instruments include one-step molecular analysis of hard-to-diagnose syndromes and integrated PCR testing.
Qiagen offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation, which run on QIAGEN instruments and technologies. They also provide human ID/forensics assay consumables, such as short tandem repeat assays for human ID and assays for food contamination.
The company supplies PCR instruments, including digital PCR and qPCR solutions, and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services.
Furthermore, the company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. Qiagen was founded in 1984 and is headquartered in Venlo, the Netherlands.
